HAL (France)open access
Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model
Therapeutic antibody, R1Mab1, 1, Amyotrophic lateral sclerosis, Metabolomics, FGF21, 0, SODG93A
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 202532
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.